Cannabis Use for Chronic Pain in Sickle Cell Disease: A Scoping Review
- 24 July 2025
- journal article
- review article
- Published by Elsevier in Pain Management Nursing
- Vol. 27 (1) , e17-e25
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Chronic pain management in sickle cell disease: A systematic scoping review of controlled trialsCritical Reviews in Oncology/Hematology, 2023
- Systematic Review and Meta-analysis Seem to Indicate that Cannabinoids for Chronic Primary Pain Treatment Have Limited BenefitPain and Therapy, 2022
- Sickle Cell DiseaseJAMA, 2022
- Review of the Endocannabinoid SystemBiological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2020
- Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell DiseaseJAMA Network Open, 2020
- Sensitivities to Thermal and Mechanical Stimuli: Adults With Sickle Cell Disease Compared to Healthy, Pain-Free African American ControlsThe Journal of Pain, 2019
- Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid EpidemicJAMA Network Open, 2019
- Why Insurance Companies Should Pay for Medical CannabisThe American Journal of Bioethics, 2019
- Marijuana Use in Adults Living with Sickle Cell DiseaseCannabis & Cannabinoid Research, 2018
- The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive CrisesCannabis & Cannabinoid Research, 2017